Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

mark_walport_wellcome_trust

Wellcome Trust appoints UK chief scientific adviser

July 3, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing UK government, Wellcome Trust

The director of the Wellcome Trust since 2003 Sir Mark Walport has been appointed to succeed Sir John Beddington as …
Appointment
Alzheimer's brain

MPs warn of dementia delays

July 3, 2012 Research and Development, Sales and Marketing APPG, Alzheimer's, dementia, government

Patients with dementia are facing huge delays in their diagnosis and treatment according to a group of MPs and peers. …
News
screen_shot_2012-07-03_at_10

ICON announces senior clinical and laboratory appointments

July 3, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing ICON

ICON, provider of outsourced development services to the pharma, biotech and medical device industries has announced appointments to the senior …
Appointment
rsa

RSA appoints new managing director for RSA Germany

July 3, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Kristian Juergensen, appointment, recruitment firm, rsa

RSA, the life sciences recruitment specialist, has appointed Kristian Juergensen as its new managing director of RSA in Germany. Juergensen …
Appointment
GSK image

GSK and Theravance post COPD pill data

July 2, 2012 Research and Development, Sales and Marketing COPD, GSK, LABA, LAMA, Theravance

GSK and partner Theravance have released new data for its combination COPD drug. Results from four late-stage trials suggest that …
News

Cmed Clinical Services launches new corporate brochure

July 2, 2012 Research and Development

Cmed Clinical Services is a long-established, flexible CRO with offices in the UK, US and Romania offering project management, clinical …
News
Press release
mark-porter-dr_2161169b

Doctors’ union the BMA appoints new chairman

July 2, 2012 Medical Communications, Research and Development, Sales and Marketing BMA, Dr Mark Porter, appointment

Dr Mark Porter, a consultant anaesthetist in Coventry, has been elected new chairman of the British Medical Association’s UK Council. …
Appointment
LaMattina image

John LaMattina: FDA tries to disavow role in higher hurdles for new drugs

July 2, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, John LaMattina, Pfizer, US, discovery, drug

As evidenced by various blog posts that I have written over the past year (e.g., “Why Doesn’t the FDA Get …
Feature
EMA image

EMA publishes updated diabetes guidelines

July 2, 2012 Research and Development, Sales and Marketing Avandia, EMA, GSK, R&D, Takeda

The European Medicines Agency has published new guidance on what it wants to see from firms submitting new diabetes treatments. …
News
ariad_slideshow-3

Ariad touts next generation CML treatment

June 29, 2012 Research and Development, Sales and Marketing Ariad, CML, Cancer, Europe, Switzerland

Ariad Pharmaceuticals is to expand into Europe following promising results for an investigational cancer drug. The US biotech firm will …
News

MRN gets SMART with its clinical trial scheduling

June 28, 2012 Research and Development clinical trials, electronic data capture, medical research network, mrn, patient scheduling

Medical Research Network (MRN), the unique Clinical Trial Support Organisation (CTSO) offering home trial and site nurse support as well …
News
Press release

Astellas submits new prostate cancer drug to EMA

June 28, 2012 Research and Development, Sales and Marketing Astellas, EMA, Medivation, NICE, Zytiga, enzalutamide

Astellas has submitted its investigational prostate cancer drug enzalutamide to the European Medicines Agency. Enzalutamide is a once-daily pill that works …
News

Amylin withheld safety data, says FDA

June 27, 2012 Research and Development, Sales and Marketing Amylin, Bydureon, Byetta, FDA, lilly

The US medicines regulator says Amylin held back data relating to the safety of its diabetes drug Bydureon. The allegation …
News

Roche cuts 1,000 R&D jobs

June 27, 2012 Research and Development, Sales and Marketing AZ, Genentech, Novartis, R&D, Roche, cuts

Roche will make major cuts to its research operations in the US and revamp operations in Europe. Roche will close …
News
Roche image

Roche’s Perjeta increases survival

June 27, 2012 Research and Development, Sales and Marketing EMA, FDA, Herceptin, Perjeta, Roche, breast cancer

Roche’s new drug Perjeta has scored another trial success by increasing overall survival in certain breast cancer patients. The new …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025